1Belani CP,Ramalingam S,Schreeder M,et al.PhaseⅡstudy of cet-uximab in combination with cisplatin and docetaxel for panients with advanced/metastatic non-small-cell lung cancer(NSCLC)〔J〕[].Journal of Clinical Oncology.2007
2Messersmith WA,,Hidalog M.Panitumumab,a monoclonal anti epider-mal growth factor receptor antibody in colorectal cancer:another one or the one-〔J〕[].Clinical Cancer Research.2007
3Kirs MG,Natale RB,Herbst RS,et al.Efficacy of gefitinib,an inhibi-tor of the epidermal growth factor receptor tyrosine kinase,in symp-tomatic patients with non-small-cell lung cancer:a randomized trial〔J〕[].The Journal of The American Medical Association.2003
4Kim ES,Hirsh V,Mok T,et al.Gefitinib versus docetaxel in previous-ly treated non-small-cell lung cancer(INTEREST):randomised phaseⅢtrial〔J〕[].The Lancet.2008
5Shepherd FA,Rodrigues preeira J,Ciuleanu T,et al.Erloinib in previ-ously treated non-small-cell lung cancer〔J〕[].The New England Journal of Medicine.2005
6Bezjak A,Tu D,Seymour L,et al.Symptom improvement in lung cancer patients treated with relotinib:quality of life analysis of theNational Cancer Institute of Canada Clinical Trials Group Study〔J〕[].Journal of Clinical Oncology.2006
7Lacouture ME.Mechanisms of cutaneous toxicities to EGFR inhibitors〔J〕[].Nature Reviews Cancer.2006
8Mendelsohn J.The epidermal growth factor receptor as a target for cancer therapy[].Endocrine Related Cancer.2001
9Perez-Soler R,Chachoua A,Hammond LA,et al.Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer[].Journal of Clinical Oncology.2004
10Baselga J,Pfister D,Cooper MR,et al.Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin[].Journal of Clinical Oncology.2000
